Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FE 999169 vs Niflec for Colon Cleansing
NCT02215954Phase 3Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Sep 2014
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sodium picosulfate + magnesium oxide + citric acid, sponsored by Ferring Pharmaceuticals. Started Sep 2014; status: completed.
02
Drugs
sodium picosulfate + magnesium oxide + citric acid
Beyond the preview
Go deeper on NCT02215954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02215954.